Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 9 matching records
NINDS' DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP): SHAMLOO-SELECTIVE CB2 AGONIST; MRI RESEARCH INC:1186811 [26-000042]Department of Health and Human Services$1.4M obligationsEnds Aug 14, 2030
THE PURPOSE OF THIS REQUIREMENT IS TO CONTRACT FOR API AND DILUENTDepartment of the Interior$739.9K obligationsEnds Sep 19, 2028
MRI GLOBAL - MILLER DMFPDepartment of Health and Human Services$2.4M obligationsEnds Jan 31, 2027
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)Department of Health and Human Services$514.9K obligationsEnds Jan 14, 2025
SLAUGENHAUPT-MGH DMFP FOR BPN36964 (PTC680)Department of Health and Human Services$2.1M obligationsEnds Sep 18, 2029
EVALUATION OF SHELF-LIFE OF SAMPLES OF INVESTIGATIONAL CLINICAL DRUG FORMULATIONS, TO INCLUDE PARENTERAL, ORAL, AND OTHER TYPES OF DOSAGE FORMS.Department of Health and Human Services$949.3K obligationsEnds Jan 31, 2026
IDP PRODUCTION FOR THE KETAMINE PROGRAM-QUOTE # NIH-OLAO 0001Department of Health and Human Services$2.3M obligationsEnds Feb 18, 2025
DRUG SHELF LIFE TESTINGDepartment of Health and Human Services$1.7M obligationsEnds Jul 31, 2023
PADERI HEAL PROJECT-IHP-102Department of Health and Human Services$729.9K obligationsEnds Aug 7, 2029